Samantha J. Allen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samantha J. Allen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Tracy M. Handel
University of California, San Diego
2 shared publicationsBrian A. Zabel
Stanford University School of Medicine
1 shared publication- Daniel Nietlispach
Department of Biochemistry, University of Cambridge, Cambridge, UK
1 shared publication Eugene C. Butcher
Stanford University School of Medicine
1 shared publicationJohn Kirkpatrick
University of Cambridge
1 shared publicationSusan E. Crown
Skaggs School of Pharmacy and Pharmaceutical Science, University of California, San Diego, La Jolla, California 92093
1 shared publication
Latest Publications
- 11 September 2007
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 1 (2) , 171-173
NMR assignment of human chemerin, a novel chemoattractant
Chemerin is a potent chemoattractant for cells expressing the GPCR CMKLR1, and is thought to play important roles in cell migration and recruitment to sites of tissue damage and inflammation. Here we report the NMR assignments of the 15.6 kDa active form of uniformly 15N, 13C labeled chemerin.
- 11 September 2007
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 1 (2) , 171-173
NMR assignment of human chemerin, a novel chemoattractant
Chemerin is a potent chemoattractant for cells expressing the GPCR CMKLR1, and is thought to play important roles in cell migration and recruitment to sites of tissue damage and inflammation. Here we report the NMR assignments of the 15.6 kDa active form of uniformly 15N, 13C labeled chemerin.
- Top Cited Papers
- 1 April 2007
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 25 (1) , 787-820
Chemokine:Receptor Structure, Interactions, and Antagonism
Chemokines are critical mediators of cell migration during routine immune surveillance, inflammation, and development. Chemokines bind to G protein–coupled receptors and cause conformational changes that trigger intracellular signaling pathways involved in cell movement and activation. Although chemokines evolved to benefit the host, inappropriate regulation or utilization of these proteins can contribute to or cause many diseases. Specific chemokine receptors provide the portals for HIV to get into cells, and others contribute to inflammatory diseases and cancer. Thus, there is significant interest in developing receptor antagonists. To this end, the structures of ligands coupled with mutagenesis studies have revealed mechanisms for antagonism based on modified proteins. Although little direct structural information is available on the receptors, binding of small molecules to mutant receptors has allowed the identification of key residues involved in the receptor-binding pockets. In this review, we discuss the current knowledge of chemokine:receptor structure and function, and its contribution to drug discovery.
- 1 April 2007
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 25 (1) , 787-820
Top Cited PapersChemokine:Receptor Structure, Interactions, and Antagonism
Chemokines are critical mediators of cell migration during routine immune surveillance, inflammation, and development. Chemokines bind to G protein–coupled receptors and cause conformational changes that trigger intracellular signaling pathways involved in cell movement and activation. Although chemokines evolved to benefit the host, inappropriate regulation or utilization of these proteins can contribute to or cause many diseases. Specific chemokine receptors provide the portals for HIV to get into cells, and others contribute to inflammatory diseases and cancer. Thus, there is significant interest in developing receptor antagonists. To this end, the structures of ligands coupled with mutagenesis studies have revealed mechanisms for antagonism based on modified proteins. Although little direct structural information is available on the receptors, binding of small molecules to mutant receptors has allowed the identification of key residues involved in the receptor-binding pockets. In this review, we discuss the current knowledge of chemokine:receptor structure and function, and its contribution to drug discovery.